Switch theme
Sign up to access all valuation multiples
Carelabs Co Ltd is an Ireland based company engages in the provision of healthcare information technology services. The company provides clinic information, clinic customer management software, and digital marketing solutions. Its healthcare media platform includes GoodDak, a mobile medical information service; and Barbietk, a healthcare service that shares domestic cosmetic, skin care, and diet reviews.
2012
n/a
LTM Revenue n/a
LTM EBITDA n/a
$33.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Carelabs has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Carelabs achieved revenue of $56.7M and an EBITDA of -$8.4M.
Carelabs expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Carelabs valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $55.8M | $56.7M | XXX | XXX | XXX |
| Gross Profit | $57.7M | $54.3M | XXX | XXX | XXX |
| Gross Margin | 103% | 96% | XXX | XXX | XXX |
| EBITDA | -$9.7M | -$8.4M | XXX | XXX | XXX |
| EBITDA Margin | -17% | -15% | XXX | XXX | XXX |
| Net Profit | -$17.8M | -$16.7M | XXX | XXX | XXX |
| Net Margin | -32% | -29% | XXX | XXX | XXX |
| Net Debt | $18.5M | $18.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Carelabs's stock price is KRW 2210 (or $2).
Carelabs has current market cap of KRW 42.9B (or $29.2M), and EV of KRW 48.5B (or $33.0M).
See Carelabs trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $33.0M | $29.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Carelabs has market cap of $29.2M and EV of $33.0M.
Carelabs's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Carelabs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Carelabs and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $33.0M | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | -3.9x | XXX | XXX | XXX |
| P/E | -2.1x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -11.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCarelabs's NTM/LTM revenue growth is n/a
Carelabs's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Carelabs's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Carelabs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Carelabs and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -15% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -13% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 63% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 104% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carelabs acquired XXX companies to date.
Last acquisition by Carelabs was XXXXXXXX, XXXXX XXXXX XXXXXX . Carelabs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Carelabs founded? | Carelabs was founded in 2012. |
| Where is Carelabs headquartered? | Carelabs is headquartered in South Korea. |
| Is Carelabs publicy listed? | Yes, Carelabs is a public company listed on KRX. |
| What is the stock symbol of Carelabs? | Carelabs trades under 263700 ticker. |
| When did Carelabs go public? | Carelabs went public in 2018. |
| Who are competitors of Carelabs? | Similar companies to Carelabs include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Carelabs? | Carelabs's current market cap is $29.2M |
| What is the current revenue growth of Carelabs? | Carelabs revenue growth between 2023 and 2024 was 2%. |
| Is Carelabs profitable? | Yes, Carelabs is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
